Home Corporate Governance AGM Summary SEC Filings Financial Reports Stock Information Press Releases Event Calendar Analyst Coverage E-mail Alerts Investor Kit Information Request Contact IR SEC Filings Receive E-mail Alerts We will provide a hard copy of our complete audited financial statements, free of charge, to our shareholders and ADS holders upon request. Please send your request to: Simcere Pharmaceutical Group No.699-18, Xuanwu Avenue, Xuanwu District, Nanjing, P.R. China, 210042 Tel: +86 25 8556 6666x8857 Fax:+86 25 8547 1729 E-mail: IR@simcere.com SEC Filing Keyword Search (View search tips) Groupings Filter (View SEC Groupings descriptions) All FormsAnnual FilingsCurrent ReportsOtherRegistration Statements View Section 16 Filings (3,4,5) << First | Previous | Next | Last >> Filing Date Form Description Filing Group Downloads 11/16/09 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 08/18/09 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 07/27/09 SC 13D/A An amendment to a SC 13D filing Other 07/23/09 EFFECT EFFECT Other 07/13/09 F-3 Registration statement for certain foreign private issuers offered for certain transactions Registration Statements 06/18/09 20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g) Annual Filings 05/19/09 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 04/21/09 F-X F-X Other 04/21/09 CB CB Other 03/12/09 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports << First | Previous | Next | Last >>

Copyright 2000- www.simcere.com/english All rights reserved. Tel. 86-25-85566666 fax 86-25-85471729 Design by 71nc.com